Importantly, a functional nuclear CXCR4 may contribute to PCa relapse despite current antagonists and monoclonal antibodies against PM-bound CXCR4 and may not be designed to cross the PM, which would be required to antagonize active CXCR4 at the nucleus. Here, CXCR4 is linked to posterior cortical atrophy.